Stay updated on HELIOS-B: Vutrisiran in TTR Amyloidosis Cardiomyopathy Clinical Trial
Sign up to get notified when there's something new on the HELIOS-B: Vutrisiran in TTR Amyloidosis Cardiomyopathy Clinical Trial page.

Latest updates to the HELIOS-B: Vutrisiran in TTR Amyloidosis Cardiomyopathy Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting NLM-NCBI services and products, as well as a specific date. Additionally, a new date has been added.SummaryDifference6%
- Check30 days agoNo Change Detected
- Check38 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for the Help Desk.SummaryDifference6%
- Check45 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.3%
- Check59 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.3%
- Check66 days agoChange DetectedThe website has updated the 'type of intervention' feature to version 2.14.0 on January 9, 2025, following the removal of the previous version 2.13.3 on December 10, 2024.SummaryDifference2%
- Check95 days agoChange DetectedThe website has been updated to version 2.13.3 on December 10, 2024, following the deletion of version 2.13.2 on November 13, 2024.SummaryDifference1.0%
Stay in the know with updates to HELIOS-B: Vutrisiran in TTR Amyloidosis Cardiomyopathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HELIOS-B: Vutrisiran in TTR Amyloidosis Cardiomyopathy Clinical Trial page.